Author: Karl

Auris Medical Holding AG Announces Launch and Pricing of IPO

Auris Medical Holding AG —the developer of treatments for acute inner ear tinnitus (AM-101) and acute inner ear hearing loss (AM-111) by way of intratympanic injection—announced on August 6 pricing of its IPO. The company’s common shares have been approved for listing on the NASDAQ Global Market and are expected to begin trading under the ticker symbol “EARS”.

Read More

SEO Survival Guide for Hearing Care Practices

If you are wanting to enter the search market and grow your brand—essentially crossing the Rubicon for the first time—you should know that, depending on your market, competition can be fierce. But a strong effort to grow visibility and differentiate your brand from those against the competitive backdrop is the surest strategy for success.

Read More